Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hans-Arnold Stoehr is active.

Publication


Featured researches published by Hans-Arnold Stoehr.


Archive | 2001

Stabilized protein preparation and process for its preparation

Juergen Roemisch; Harald Stauss; Hans-Arnold Stoehr


Archive | 2000

Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography

Juergen Roemisch; Annette Feussner; Hans-Arnold Stoehr


Archive | 2008

Procedure for the determination of the activity of the protease which activates factor VII from protein solutions

Juergen Roemisch; Annette Feussner; Hans-Arnold Stoehr


Archive | 2001

Mutants of the factor VII-activating protease and detection methods using specific antibodies

Juergen Roemisch; Hans-Arnold Stoehr; Annette Feussner; Wiegand Lang; Thomas Weimer; Margret Becker; Claudia Nerlich; Gudrun Muth-Naumann; Bernd Knoblauch


Archive | 1995

Composition containing prothrombincomplex-concentrate and at least one additional component which activates the coagulation, as antidote for blood-anticoagulants

Juergen Roemisch; Karl-Heinz Dr Diehl; Hans-Arnold Stoehr


Archive | 2003

Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis

Stefan Kiechl; Johann Willeit; Christian Josef Wiedermann; Juergen Roemisch; Thomas Weimer; Annette Feussner; Hans-Arnold Stoehr; Volker Doersam; Wiegand Lang; Margret Becker; Claudia Nerlich; Gudrun Muth-Naumann; Bernd Knoblauch


Archive | 2003

Inhibitory monoclonal antibody against blood clotting factor VII-activating protease

Juergen Roemisch; Wiegand Lang; Annette Feussner; Gudrun Muth-Naumann; Hans-Arnold Stoehr; Christian Kannemaier; Klaus T. Preissner; Fumie Nakazawa


Archive | 2002

New nucleic acid encoding mutant factor 7 activating protease, useful for diagnosis, treatment and prevention of coagulation disorders, also related protein and antibodies

Thomas Weimer; Juergen Roemisch; Margret Becker; Annette Feusner; Claudia Nerlich; Hans-Arnold Stoehr


Archive | 2013

Sugar Compositions for Treating Hemophilia A and/or Von Willebrand Disease

Stefan Schulte; Rolf Spirig; Sabine Zollner; Michael Moses; Wilfried Wormsbaecher; Hans-Arnold Stoehr


Archive | 2002

BLOOD COAGULATION FACTOR VII-ACTIVATING-PROTEASE AND STABLE LIQUID PREPARATION CONTAINING PROENZYME THEREOF

Annette Feussner; Christian Kannemeier; Juergen Roemisch; Hans-Arnold Stoehr; アネッテ・フォイスナー; クリスティアン・カネマイアー; ハンス−アルノルト・シュテーア; ユアゲン・レーミシュ

Collaboration


Dive into the Hans-Arnold Stoehr's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fumie Nakazawa

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge